The Global Medtech Industry: Rewiring Medtech in a Post-Pandemic World
The medtech industry is undergoing rapid change to address evolving global market dynamics. This has been further accelerated by the pandemic. This white paper from IQVIA – an associate member of AdvaMed® – discusses how global markets and specific therapeutic areas are poised for growth over the next decade. Read this white paper to help inform business strategy.
Related Reading
News / Government & Legislative Affairs / Tariff
AdvaMed® Statement on Today’s Tariff Announcement
April 2, 2025
Today, AdvaMed®, the Medtech Association, the largest global trade organization representing medical technology companies, released its “Medical Innovation Agenda for the 119th Congress.” These policy priorities would advance AdvaMed®’s goal to usher in a new era of health care innovation on behalf of all American patients, promoting access to the latest lifesaving technologies.
Blog / Coverage & Payment / Diagnostics / Global & Trade / Government & Legislative Affairs / Regulatory Affairs / Small Business
AdvaMed®’s Medical Innovation Agenda for the 119th Congress
March 28, 2025
AdvaMed®’s medtech priorities for the 119th Congress highlight opportunities to address the most important issues facing patients and the medical technology industry today.
Resource / Compliance / Global & Trade / Regulatory Affairs
State of the Nation 2025: Global Medical Device Recall Index Report
March 27, 2025
Download Sedgwick’s Global Medical Device Recall Report for key insights on compliance, regulations, and global recall trends. Members only.
Event / China / Global & Trade / Government & Legislative Affairs / Supply Chain
Tariffs: Navigating Customs Origins Requirements for tariffs, USMCA exemptions and beyond (Members Only)
April 4, 2025
10:30 AM – 12:00 PM
Exclusive member webinar on tariffs, customs, USMCA rules of origin, and compliance strategies with expert Larry Friedman. April 4, 10:30 AM ET. Register now!
Resource / Coverage & Payment / Diagnostics / Global & Trade / Government & Legislative Affairs / Health Equity / Legal / Regulatory Affairs / Small Business
The Medical Innovation Agenda for the 119th Congress
March 13, 2025
AdvaMed®’s medtech priorities for the 119th Congress highlight opportunities to address the most important issues facing patients and the medical technology industry today.
Resource / Executive Orders / Global & Trade / Government & Legislative Affairs / Supply Chain / Tariff
Health Care Organizations on Concerns & Exemptions Regarding Tariffs
March 6, 2025
Tariffs on medical goods threaten healthcare costs, access, and supply chains. Leading health groups urge exemptions to safeguard patient care.
Event / Global & Trade / Legal
Navigating Inbound Trade & Investment: Strategies for Medtech in the Era of Tariffs & Trade Legal and Policy Shifts
March 19, 2025: 1:00pm – 2:00pm ET
Akin will provide a CLE program covering the latest legal issues for inbound trade and investment, including the Trump Administration’s approach to trade policy and tariff issues, and strategies medical technology companies can employ to assess and mitigate legal risk. Attendees are eligible to receive 1.0 CLE.
Resource / Global & Trade / Government & Legislative Affairs / Tariff
AdvaMed® Tariff Talking Points
February 27, 2025
Essential advocacy insights on how new tariffs impact the MedTech industry. Use these key messages when engaging with policymakers, industry stakeholders, and media.